- Release Date: 18/06/21 10:03
- Summary: SUDA Licenses a Novel iNKT Cell Therapy Platform
- Price Sensitive: Yes
- Download Document 224.1KB
- Forums
- ASX - By Stock
- ALA
- Ann: SUDA Licenses a Novel iNKT Cell Therapy Platform
ALA
arovella therapeutics limited
Add to My Watchlist
2.38%
!
10.3¢

Ann: SUDA Licenses a Novel iNKT Cell Therapy Platform
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
10.3¢ |
Change
-0.003(2.38%) |
Mkt cap ! $118.8M |
Open | High | Low | Value | Volume |
10.0¢ | 10.3¢ | 10.0¢ | $23.40K | 231.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 60662 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 515139 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 60662 | 0.100 |
4 | 91630 | 0.099 |
2 | 95333 | 0.098 |
3 | 56700 | 0.097 |
1 | 105000 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 515139 | 7 |
0.110 | 459888 | 6 |
0.115 | 287706 | 3 |
0.120 | 205608 | 7 |
0.125 | 515476 | 5 |
Last trade - 11.56am 30/07/2025 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |